Myriad Genetics Agrees to Sell Prenatal Testing Business to Labcorp
Myriad Genetics agreed to sell its Prenatal Health testing business to Labcorp for $210 million in cash plus inventory value. Myriad shares rose 22.2% in premarket trading.
What Happened? Shares of genetic testing company Myriad Genetics NASDAQ:MYGNjumped 22.2% in the pre-market session after the company agreed to sell its Prenatal Health testing business to Labcorp for $210 million in cash plus inventory value.Under the definitive asset purchase agreement, Labcorp wi…